Barcelona-based Aelix Therapeutics has appointed Dr Melanie Rolli as CEO. Her predecessor, Dr Jose Luis Cabero, had decided to step down from executive positions at Aelix
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2021-05-18 16:00:502021-05-18 16:00:50AELIX: Next stage with new CEO
https://european-biotechnology.com/wp-content/uploads/2024/04/BD.png234445Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-05-18 12:45:322021-05-18 12:45:32BD installs production hub in Zaraogza
Immunoglobin G antibodies (IgG) produced in response to the SARS-CoV-2 spike protein appear to play a role in how COVID-19 can turn more severe in some cases.
https://european-biotechnology.com/wp-content/uploads/2024/04/novel-coronavirus-sars-cov-2_49557785797_o.jpg17162116Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-05-11 17:10:262021-05-11 17:10:26SARS-CoV-2-antibodies may promote severe COVID-19
The Biden administration has announced it will support the WHO proposal to temporarily waive intellectual property rights for COVID-19 vaccines to speed up vaccination.
https://european-biotechnology.com/wp-content/uploads/2024/04/COVshield.jpg9601440Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-05-06 06:41:002021-05-06 06:41:00USA supports to temporarily waive IP of COVID-19 vaccines
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2021-05-06_um_06.30.32.png402662Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-05-06 06:31:002021-05-06 06:31:00Swiss Oculis SA raises $57m in Series C
Cell reprogramming specialist Mogrify Ltd has announced the second closing of its Series A financing of $17m, bringing the total raised to $33m in this round.
https://european-biotechnology.com/wp-content/uploads/2024/04/Mogrify.jpg7502000Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-05-04 13:32:332021-05-04 13:32:33Mogrifiy completes Series A financing round
AELIX: Next stage with new CEO
AppointmentsBarcelona-based Aelix Therapeutics has appointed Dr Melanie Rolli as CEO. Her predecessor, Dr Jose Luis Cabero, had decided to step down from executive positions at Aelix
BD installs production hub in Zaraogza
Latest NewsBD will build a €165m manufacturing facility in Zaragoza, Spain to support the growth of its pre-filled drug delivery business.
COVID-19 therapeutics: Germany launches €300m funding
Latest NewsGerman government has launched a €300m programme designed to bring clinically tested COVID-19 treatments to the patient’s bedside.
Recombinant silk producer AMSilk raises €29m
Latest NewsAMSilk GmbH has closed a Series C financing at €29m to accelerate and expand commercialisation of its microbially produced silk fibres.
SARS-CoV-2-antibodies may promote severe COVID-19
Latest NewsImmunoglobin G antibodies (IgG) produced in response to the SARS-CoV-2 spike protein appear to play a role in how COVID-19 can turn more severe in some cases.
Abingworth raises $582m for late-stage fund ACCD 2
Latest NewsInternational life sciences investment group Abingworth has closed a new clinical co-development fund at US$582m.
USA supports to temporarily waive IP of COVID-19 vaccines
Latest NewsThe Biden administration has announced it will support the WHO proposal to temporarily waive intellectual property rights for COVID-19 vaccines to speed up vaccination.
Swiss Oculis SA raises $57m in Series C
Latest NewsTopical ophthalmic therapies developer Oculis S.A. has closed a US$57m Series C financing to push development of its pipeline.
New entrant at Celyad
AppointmentsBelgium-based Celyad has had a new CMO since April: Dr Charles Morris.
Mogrifiy completes Series A financing round
Latest NewsCell reprogramming specialist Mogrify Ltd has announced the second closing of its Series A financing of $17m, bringing the total raised to $33m in this round.